Rishabh Chaudhary

Rishabh Chaudhary

Auto-generated profile, based on publicly available information

Rishabh Chaudhary

Department of Pharmacology, M. M. College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, India

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2024 in Antioxidants
Verified
Journal Article
Open access
PDF file
MKMateusz Kciuk
Mateusz Kciuk
AGAnjali Garg
Anjali Garg
MRManni Rohilla
Manni Rohilla
RCRishabh Chaudhary
Rishabh Chaudhary
SDSanchit Dhankhar
Sanchit Dhankhar
RKRenata Kontek
Renata Kontek
Rheumatoid arthritis (RA) is a persistent autoimmune disorder that is characterized by joint inflammation, discomfort, and impairment. Despite the existence of several therapeutic approaches, their effectiveness is often restricted and may be linked to unfavorable side effects. Consequently, there has been growing interest in investigating naturally derived compounds as plausible therapeutic agents for RA disease. The objective of this review is to summarize the existing preclinical and clinical evidence regarding the efficacy of naturally extracted compounds and plant extracts in the treatment of RA, focusing on their anti-inflammatory, anti-oxidative, and immunomodulatory properties. Some of the problems with using natural chemicals are the uneven quality of commercially available preparations and the poor bioavailability of these compounds. Future investigations should focus on improving the formulations, conducting thorough clinical trials, and exploring different techniques to fully utilize the intrinsic potential of naturally derived chemicals in treating RA.

24 July 2025 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
RCRishabh Chaudhary
Rishabh Chaudhary
NBNitin Bansal
Nitin Bansal
AKAmanpreet Kaur
Amanpreet Kaur
SGSumeet Gupta
Sumeet Gupta
KCKanwaljit Chopra
Kanwaljit Chopra
SBSeema Bansal
Seema Bansal

1 September 2023 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
RCRishabh Chaudhary
Rishabh Chaudhary
MRManni Rohilla
Manni Rohilla
SCSAMRAT CHAUHAN
SAMRAT CHAUHAN
MSMonika Saini
Monika Saini
SAShahbaz Aman
Shahbaz Aman
SMSachin Mehta
Sachin Mehta
Objective: This review aims to explore the impact of the COVID-19 pandemic on mental health, with a focus on the physiological and psychological consequences, including comorbidities. The goal is to understand the direct and indirect populations affected by mental distress and identify potential interventions. Methodology: A comprehensive literature search was conducted using various databases, including Google Scholar, ResearchGate, ScienceDirect, PubMed, PLoS One, and Web of Science. The search utilized relevant keywords to investigate the direct and indirect impacts of COVID-19 on mental health. The selected articles were critically evaluated and analyzed to identify key findings and insights. Main findings: Mental health, being an intrinsic component of overall well-being, plays a vital role in physiological functioning. The COVID-19 pandemic, caused by the emergence of the novel SARS-CoV-2 virus, has had a devastating global impact. Beyond the respiratory symptoms, individuals recovering from COVID-19 commonly experience additional ailments, such as arrhythmia, depression, anxiety, and fatigue. Healthcare professionals on the frontlines face an elevated risk of mental illness. However, it is crucial to recognize that the general population also grapples with comparable levels of mental distress. Conclusion: The COVID-19 pandemic has underscored the significance of addressing mental health concerns. Various strategies can help mitigate the impact, including counselling, fostering open lines of communication, providing mental support, ensuring comprehensive patient care, and administering appropriate medications. In severe cases, treatment may involve the supplementation of essential vitamins and antidepressant therapy. By understanding the direct and indirect impacts of COVID-19 on mental health, healthcare providers and policymakers can develop targeted interventions to support individuals and communities affected by the pandemic. Continued research and collaborative efforts are essential to address this pervasive issue effectively.

22 October 2025 in Journal of Neuroimmune Pharmacology
Verified
Journal Article
Closed access
PDF file
RCRishabh Chaudhary
Rishabh Chaudhary
RLRoshan Lal
Roshan Lal
NBNitin Bansal
Nitin Bansal
NGNancy Garg
Nancy Garg
MBMahendra Bishnoi
Mahendra Bishnoi
SBSeema Bansal
Seema Bansal

19 December 2025 in European Journal of Pharmacology
Verified
Journal Article
Closed access
RCRishabh Chaudhary
Rishabh Chaudhary
SBSowvik Bag
Sowvik Bag
NBNitin Bansal
Nitin Bansal
RLRoshan Lal
Roshan Lal
MBMahendra Bishnoi
Mahendra Bishnoi
SBSeema Bansal
Seema Bansal

1 April 2023 in Endocrine, Metabolic & Immune Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
RCRishabh Chaudhary
Rishabh Chaudhary
SGSumeet Gupta
Sumeet Gupta
SCSAMRAT CHAUHAN
SAMRAT CHAUHAN
Background: Uncoupling proteins (UCPs) are unpaired electron carriers that uncouple oxygen intake by the electron transport chain from ATP production in the inner membrane of the mitochondria. The physiological activities of UCPs have been hotly contested, and the involvement of UCPs in the pathogenesis and progression of diabetes mellitus is among the greatest concerns. UCPs are hypothesised to be triggered by superoxide and then reduce mitochondrial free radical production, potentially protecting diabetes mellitus patients who are experiencing oxidative stress. Objectives: The objectives of the study are to find out the newest ways to treat diabetes mellitus through protein uncoupling. Methods: Research and review papers are collected from different databases like google scholar, PubMed, Mendeley, Scopus, Science Open, Directory of open access journals, and Education Resources Information Center, using different keywords such as “uncoupling proteins in diabetes mellitus treatment”, “UCP 1”, “UCP 2”, and ‘UCP 3”. Results: UCP1, UCP2, and UCP 3 are potential targets as uncoupling proteins for the treatment of diabetes mellitus for new drugs. New drugs treat the disease by reducing oxidative stress through thermogenesis and energy expenditure. Conclusion: UCP1, UCP2, and UCP3 have a role in fatty acid metabolism, negative control of insulin production, and insulin sensitivity by beta-cells. Polymorphisms in the UCP 1, 2, and 3 genes significantly reduce the risk of developing diabetes mellitus. Protein uncoupling indirectly targets the GPCR and islet of Langerhans. This review summarises the advances in understanding the role of UCP1, UCP2, and UCP3 in diabetes mellitus.